# OnCo record aptose (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aptose/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aptose" ;
  schema:name "Aptose Biosciences"@en ;
  schema:alternateName "Aptose Biosciences Inc."@en, "Aptose"@en ;
  schema:description "Aptose is a San Diego and Toronto company developing tuspetinib, an oral kinase inhibitor acting on FLT3, SYK, JAK and other targets, for acute myeloid leukaemia in combination with venetoclax and azacitidine."@en ;
  schema:url <https://onco.cc/companies/aptose/>, <https://www.aptose.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.aptose.com>, <https://clinicaltrials.gov/search?lead=Aptose%20Biosciences> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/>, <https://onco.cc/drugs/tuspetinib/> .